Skip to main content
TipRanks
Go Ultimate75% OFF

Nell Beattie Insider Profile

11 Followers

Nell Beattie, former CFO, Head of Corp. Development, Director at VBI Vaccines, holds 68.20K shares in VBI Vaccines (Ticker: VBIVQ). Most recently, Nell Beattie Bought 8,200 shares of VBI Vaccines on Dec 06, 2021 for an estimated value of $20.01K.

Nell Beattie's Trading History

VBIVQ
VBI Vaccines
Dec 06, 2021―Informative Buy20.01K$682.00
VBIVQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 06, 2021Informative Buy$20.01K8,200$2.44-79.10%
Oct 01, 2019Informative Buy$4.80K10,000$0.48+470.20%
Jun 19, 2019Informative Buy$5.84K8,000$0.73+266.30%
Jun 18, 2019Uninformative Buy$11.81K6,250$1.89―
Feb 04, 2019Uninformative Buy$0.0015,000$0.00―

You May Also Like

Nell Beattie insider profile FAQ

What is the percentage of profitable transactions made by Nell Beattie?
The percentage of profitable transactions made by Nell Beattie is 67%.
What is the average return per transaction made by Nell Beattie?
The average return per transaction made by Nell Beattie is 219.10%.
What stocks does Nell Beattie hold?
Nell Beattie holds: VBIVQ stocks.
What was Nell Beattie’s latest transaction?
Nell Beattie’s latest transaction was an Informative Buy of $20.01K.
What was Nell Beattie's most profitable transaction?
Nell Beattie’s most profitable transaction was an Informative Buy of VBIVQ stock on October 1, 2019. The return on the trade was 470.20%.
What is Nell Beattie's role in VBI Vaccines?
Nell Beattie's role in VBI Vaccines is CFO, Head of Corp. Development, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.